Correction to: Valemetostat Tosilate: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 17
Results: 7
1
2
Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
3
Treating Biliary Tract Cancers: New Targets and Therapies.
- Published in:
- Drugs, 2022, v. 82, n. 17, p. 1629, doi. 10.1007/s40265-022-01808-x
- By:
- Publication type:
- Article
4
Teprotumumab: A Review in Thyroid Eye Disease.
- Published in:
- Drugs, 2022, v. 82, n. 17, p. 1663, doi. 10.1007/s40265-022-01804-1
- By:
- Publication type:
- Article
5
Therapeutic Landscape Beyond Immunotherapy in Advanced Urothelial Carcinoma: Moving Past the Checkpoint.
- Published in:
- Drugs, 2022, v. 82, n. 17, p. 1649, doi. 10.1007/s40265-022-01802-3
- By:
- Publication type:
- Article
6
Spesolimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 17, p. 1681, doi. 10.1007/s40265-022-01801-4
- By:
- Publication type:
- Article
7
Deucravacitinib: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 17, p. 1671, doi. 10.1007/s40265-022-01796-y
- By:
- Publication type:
- Article